Autologous human macrophages and anti-tumour cell therapy

Research in Immunology

Volumn 149, Issue 7-8, 1998, Pages 663-671

  Lesimple, T ^a   Moisan, A ^a   Toujas, L ^a  

^a Ctr Reg de Lutte Contre le Cancer   (France)

Author keywords

APC; Anti tumour cell therapy; CTL; Macrophage; Review

Indexed keywords

CYTOKINE; GAMMA INTERFERON;

ADOPTIVE IMMUNOTHERAPY; ANTIGEN PRESENTING CELL; ANTINEOPLASTIC ACTIVITY; CANCER IMMUNOTHERAPY; CELL ACTIVATION; CELL INTERACTION; CONFERENCE PAPER; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; HUMAN; MACROPHAGE; PRIORITY JOURNAL;

EID: 0032323114     PISSN: 09232494     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-2494(99)80036-4     Document Type: Conference Paper

References (70)

1. Ammon, C., Kreutz, M., Rehli, M., Krause, S.W. & Andreesen, R. (1998), Platelets-induce monocyte differentiation in serum-free culture. J. Leuk. Biol., 63, 469-476.
2. Andreesen, R., Picht, J. & Lohr, G.W. (1983), Primary cultures of human blood borne macrophages grown on hydrophobic teflon membrane. J. Immunol. Methods, 36, 295-304.
3. Andreesen, R., Bross, K.J., Osterholz, J. & Emmerich, F. (1986), Human macrophage maturation and heterogeneity: analysis with a newly-generated set of monoclonal antibodies to differentiation antigens. Blood, 67, 1257-1264.
4. Andreesen, R., Brugger, W., Scheibenbogen, C., Kreutz, M., Leser, H.G., Rehm, A. & Löhr, G.W. (1990), Adoptive transfer of tumor cytotoxic macrophages generated in vitro from circulating blood monocytes: A new approach to cancer immunotherapy. Cancer Res., 50, 7450-7456.
5. Andreesen, R., Mackensen, A., Osterholz, J., Brugger, W. & Löhr, G.W. (1988), Microculture assay for human macrophage maturation in vitro. Cell-Elisa analysis of differentiation antigen expression. Int. Arch. Allergy Appl. Immunol., 86, 281-287.
6. Audran, R., Collet, B., Moisan, A. & Toujas, L. (1995a), Fate of mouse macrophages radiolabelled with PKH-95 and injected intravenously. Nucl. Med. Biol., 22, 817-821.
7. Audran, R., Dazord, L. & Toujas, L. (1994), Interaction between human macrophages and tumor cells in three-dimensional cultures. Cancer Immunol. Immunother., 39, 299-304.
8. Audran, R., Drenou, B., Martin, A., Gaudin, A. & Toujas, L. (1995b), Reactivity of the myeloid panel with blood monocyte-derived macrophages. Leukocyte Typing V, 1052, Oxford University Press (Oxford).
9. Audran, R., Lesimple, T., Delamaire, M., Picot, C., Van Damme, J. & Toujas, L. (1996), Adhesion molecule expression and response to chemotactic agents of human monocyte-derived macrophages. Clin. Exp. Immunol., 103, 155-160.
10. Bartholeyns, J., Poindron, P. & Lombard, Y. (1988), Immunotherapy of murine sarcoma by adoptive transfer of resident peritoneal macrophages proliferating culture. Anticancer Res., 47, 6100-6103.
11. Bennett, S., Por, S.B., Cooley, M.A. & Breit, S.N. (1993), In vitro replication dynamics of human culture-derived macrophages in a long term serum-free system. J. Immunol., 150, 2364-2371.
12. + T cells. J. Clin. Invest., 94, 797.
13. Bitterman, P.B., Saltzman, L.E., Adelberg, S., Ferrans, V.J. & Crystal, R.G. (1984), Alveolar replication. One mechanism of the expansion of the mononuclear phagocyte population in the chronically inflamed lung. J. Clin. Invest., 74, 460-469.
14. Cameron, D.J. & Churchill, W.H. (1980), Cytotoxicity of human macrophages for tumor cells: enhancement by bacterial lipopolysaccharides (LPS). J. Immunol., 124, 708-712.
15. Caux, C., Dezutter, D.C., Schmitt, D. & Banchereau, J. (1992), GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature, 360, 258.
16. Celluzzi, C.M., Mayordomo, J.I., Storkus, W.J., Lotze, M.T. & Falo, L.D. (1996), Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity. J. Exp. Med., 183, 283.
17. Chakraborty, N.G., Okino, T., Stabach, P., Padula, S.J., Yamase, H. & Morse, E. (1991), Adoptive transfer of activated human autologous macrophages results in regression of transplanted human melanoma cells in SCID mice. In vivo, 5, 609-614.
18. Chokri, M., Freudenberg, M., Galanos, C., Poindron, P. & Bartholeyns, J. (1989), Antitumoral effect of lipopolysaccharides, tumor necrosis factor, interferon and activated macrophages: synergism and tissue distribution. Anticancer Res., 9, 1185-1190.
19. Chokri, M., Girard, A., Borelly, M.C., Oleron, C., Romet-Lemonne, J.L. & Bartholeyns, J. (1992), Adoptive immunotherapy with bispecific antibodies: targeting through macrophages. Res. Immunol., 143, 95-99.
20. Coulon, V., Ravaud, A., Huet, S. & Gualde, N. (1997), In vitro production of human antigen presenting cells issued from bone marrow of patients with cancer. Hematol. Cell. Ther. Oct., 39, 237-244.
21. Dougherty, G.J. & McBride, W.H. (1989), Monocyte differentiation in vitro, in "Human monocytes". Zembala-Asherson ed., Academic Press, London.
22. Dumont, S., Hartmann, D., Poindron, P., Oberling, F., Faradji, F. & Bartholeyns, J. (1988), Control of the antitumoral activity of human macrophages produced in large amount in view of adoptive transfert. Eur. J. Cancer. Clin. Oncol., 24, 1691-1698.
23. Dumont, S., Mabondzo, A., Hartmann, D., Gilgenkrantz, J.L., Kessler, R., Poindron, P. & Bartholeyns, J. (1990), Study of the dependence of human monocytes and macrophages antitumoral properties upon TNF-alpha expression or release. Anticancer Res., 10, 949-954.
24. Eischen, A., Vincent, F., Bergerat, J.P., Louis-Faradji, A., Bohbot, A. & Oberling, F. (1991), Long term cultures of human monocytes in vitro. Impact of GM-CSF on survival and differentiation. J. Immunol. Methods, 143, 209-221.
25. Eymard, J.C., Lopez, M., Cattan, A., Bouché, O., Adjizian, J.C. & Bernard, J. (1996), Phase I/II trial of autologous activated macrophages in advanced colorectal cancer. Eur. J. Cancer, 32, 1905-1911.
26. Faradji, A., Bohbot, A., Frost, H., Schmitt-Goguel, M., Siffert, J.C., Dufour, P., Eber, J.L., Lallot, C., Wiesel, M.L., Bergerat, J.P. & Oberling, F. (1991a), Phase I study of liposomal MTP-PE activated autologous monocytes administered intraperitoneally to patients with peritoneal carcinomatosis. J. Clin. Oncol., 9, 1251-1262.
27. Faradji, A., Bohbot, A., Schmitt-Goguel, M., Roeslin, N, Dumont, S., Wiesel, M.L., Lallot, C., Eber, J.L., Bartholeyns, J., Poindron, P., Morand, G., Witz, J.P. & Oberling, F. (1991b), Phase I Trial of intravenous infusion of ex vivo activated autologous blood-derived macrophages in a patient with non small cell lung cancer: toxicity and immunomodulatory effects. Cancer Immunol. Immunother., 33, 319-326.
28. Faradji, A., Bohbot, A., Schmitt-Goguel, M., Siffert, J.C., Dumont, S., Wiesel, M.L., Piemont, Y., Eischen, A., Bergerat, J.P. & Bartholeyns, J. (1994), Large scale isolation of human blood monocytes by continuous flow centrifugation leukapheresis and counterflow centrifugation elutriation for adoptive cellular immunotherapy in cancer patients. J. Immunol. Methods, 174, 297-309.
29. Fidler, I.J. (1974), Inhibition of pulmonary metastasis by intravenous injection of specifically activated macrophages. Cancer Res., 34, 1074-1078.
30. Gorelik, E., Wiltrout, R.H., Copeland, D. & Herberman, R.B. (1985), Modulation of formation of tumor metastases by peritoneal macrophages elicited by various agents. Cancer Immunol. Immunother., 19, 35-42.
31. Harwix, S., Andreesen, R., Ferber, E. & Schwamberger, G. (1992), Human macrophages secrete a tumoricidal activity distinct from tumour necrosis factor-α and reactive nitrogen intermediates. Res. Immunol., 143, 89-94.
32. Hennemann, B., Beckmann, G., Eichelmann, A., Rehm, A. & Andreesen, R. (1998), Phase I trial of adoptive immunotherapy of cancer patients using monocyte-derived macrophages activated with interferon-γ and lipopolysaccharide. Cancer Immunol. Immunother., 45, 250-256.
33. Hennemann, B., Rehm, A., Kottke, A., Meidenbauer, N. & Andreesen, R. (1997), Adoptive immunotherapy with tumor-cytotoxic macrophages derived from recombinant human granulocyte-macrophage colony-stimulating factor (rhuGM-CSF) mobilized peripheral blood monocytes. J. Immunother., 20, 365-371.
34. Hennemann, B., Scheibenbogen, C. & Andreesen, R. (1995), Biological response to intrahepatic adoptive immunotherapy with autologous interferon activated macrophages. Eur. J. Cancer, 852.
35. Hibbs, J.B., Lambert, L.H. & Remington, J.S. (1972), Possible role of macrophage mediated non specific cytotoxicity in tumor resistance. Nature New Biol., 235, 48-50.
36. Krause, S.W., Rehli, M., Kreutz, M., Schwarzfischer, L., Paulauskis, J.D. & Andreesen, R. (1996), Differential screening identifies genetic markers of monocyte to macrophage maturation. J. Leukoc. Biol., 60, 540-545.
37. Lesimple, T., Le Berre, C., Moisan, A., Guille, F., Audran, R., Masson, V. & Toujas, L. (1998), Treatment of metastatic renal cell carcinoma with activated autologous macrophages and GM-CSF. XIIth conference of the European Macrophage Study Group, Paris.
38. Lombard, Y., Bartholeyns, J., Chokri, M., Illinger, D., Hartmann, D., Dumont, S., Kaufmann, S.H.E., Landmann, R., Loor, F. & Poindron, P. (1988), Establishment and characterization of long-term cultured cell lines of murine resident macrophages. J. Leuk. Biol., 44, 391-401.
39. Lopez, M., Bony, V., Martinache, C., Vincent, F., Chokri, M., Abina, M.A. & Bernard, J. (1996), Tumoricidal potential of human macrophages grown in vitro from blood monocytes. J. Exp. Ther. Oncol., 3, 143-154.
40. Lopez, M., Fechtenbaum, J., David, B., Martinache, C., Chokri, M., Canepa, S., De Gramont, A., Louvet, C., Gorin, I., Mortel, O. & Bartholeyns, J. (1992), Adoptive immunotherapy with activated macrophages grown in vitro from blood monocytes in cancer patients: a pilot study. J. Immunother., 11, 209-217.
41. Lopez, M., Louvet, C., Martinache, C., Bony, V., Scotto, F., Barelaud, S., Jiang, R., Drapiert, J.C., Smadja, V., De Gramont, A., Beaujean, F. & Bartholeyns, J. (1994), Infusion of large quantities of autologous blood monocyte-derived in two cancer patients did not induce increased concentration of IL-6, TNF-α, soluble CD-14, and nitrate in blood plasma. Eur. Cytokine Netw., 5, 411-414.
42. 111In-oxine labelling of tumour-cytotoxic macrophages generated in vitro from circulating blood monocytes: an in vitro evaluation. Nucl. Med. Commun., 16, 357-361.
43. Martin, A., Collet, B. & Toujas, L. (1983), Differentiation of cytotoxic adherent cells from peroxidase positive cells after intraperitoneal injection of Brucella abortus organisms. Int. J. Immunopharmacol., 5, 229-233.
44. Masucci, G., Wersall, P., Ragnhammar, P. & Mellstedt, H. (1989), Granulocyte-monocyte-colony-stimulating factor augments the cytotoxic capacity of lymphocytes and monocytes in antibody dependent cellular cytotoxicity. Cancer Immunol. Immunother., 29, 288-292.
45. + CTLs from naive precursors. J. Immunol., 153, 996.
46. 111In-oxinate in patients treated by immunotherapy. Nucl. Med. Communications, 18, 465.
47. Mukherji, B., Chakraborty, N.G., Yamasaki, S., Okino, T., Yamase, H., Sporn, J.R., Kurtzman, S.K., Ergin, M.T., Ozols, J., Meehan, J. & Mauri, F. (1995), Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells. Proc. Natl. Acad. Sci. USA, 92, 8078-8082.
48. Munn, D.H., Beall, A.C., Song, D., Wrenn, R.W. & Throckmorton, D.C. (1995), Activation-induced apoptosis in human macrophages: developmental regulation of a novel cell death pathway by macrophage colony-stimulating factor and interferon-γ. J. Exp. Med., 181, 127-136.
49. Nestle, F.O., Alijagic, S., Gilliet, M., Sun, Y., Grabbe, S., Dummer, R., Bürg, G. & Shadendorf, G. (1998), Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells. Nature Med., 4, 328-332.
50. Paglia, P., Chiodoni, C., Rodolfo, M. & Colombo, M.P. (1996), Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J. Exp. Med., 183, 317.
51. Petit, J.F., Phan-Bich, L., Lemaire, G., Martinache, C. & Lopez, M. (1993), During their differentiation into macrophages, human monocytes acquire cytostatic activity independent of NO and TNF-α. Res. Immunol., 144, 277-280.
52. Porgador, A. & Gilboa, E. (1995), Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes. J. Exp. Med., 182, 255.
53. Rini, B.R., Stadler, W.M., Spielberger, R.T., Ratain, M.J. & Vogelzang, N.J. (1998), Granulocyte-macrophage-colony stimulating factor in metastatic renal cell carcinoma. Cancer, 82, 1352-1358.
54. Rehli, M., Krause, S.W., Kreutz, M. & Andreesen, R. (1995), Carboxypeptidase M is identical to the MAX.1 antigen and its expression is associated with monocyte to macrophage differentiation. J. Biol. Chem., 270, 15644-15649.
55. Romani, N., Gruner, S., Brang, D., Kämpgen, E., Lenz, A., Trockenbacher, B., Konwalinka, G., Fritsch, P.O., Steinman, R.M. & Schuler, G. (1994), Proliferating dendritic cell progenitors in human blood. J. Exp. Med., 180, 83.
56. Salahuddin, S.Z., Markham, P.D. & Gallo, R.C. (1982), Establisment of long-term monocyte suspension cultures from human peripheral blood. J. Exp. Med., 155, 1842-1857.
57. Sallusto, F. & Lanzavecchia, A. (1994), Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor-α. J. Exp. Med., 179, 1109.
58. Sechler, J.M.G., Warren, M.K. & Gallin, J.I. (1989), Human non-transformed monocytes-derived macrophage cell lines. J. Immunol. Methods, 119, 277-285.
59. Stevenson, H.C., Miller, P., Akiyama, Y., Favilla, T., Beman, J.A., Herbeman, R., Stull, H., Thurman, G., Maluish, A. & Oldham, R. (1983), A system for obtaining large numbers of cryopreserved human monocytes purified by leukapheresis and couter-current centrifugation elutriation (CCE). J. Immunol. Methods, 62, 353-363.
60. Stevenson, H.C., Keenan, A.M. & Woodhouse, C. (1987), Fate of gamma-interferon-activated killer blood monocytes adoptively transfered into the abdominal cavity of patients with peritoneal carcinomatosis. Cancer Res., 47, 6100-6103.
61. Toujas, I., Delcros, J.G., Diez, E., Gervois, N., Semana, G., Corradin, G. & Jotereau, F. (1997), Human monocyte-derived macrophages and dendritic cells are comparably effective in in vitro presenting HLA class I-restricted peptides. Immunology, 91, 635-642.
62. Traversari, C., Van der Bruggen, P., Luescher, I.F., Lurquin, C., Chomez, P., Van Pel, A., de Plaen, E., Amar-costesec, A. & Boon, T. (1992), A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 cytolytic lymphocytes directed against tumor antigen MZ2-E. J. Exp. Med., 176, 1453.
63. Unanue, E.R. & Askonas, B.A. (1968), The immune response of mice to antigens in macrophages. Immunology, 15, 287.
64. Van der Meer, J.W.M., Van de Grevel, J.S., Beelen, R.H.J., Fluitsma, D., Hoefsmit, E.C.M. & Van Furth, R. (1982), Culture of bone marrow in the teflon bags: identification of the human monoblast. J. Ret. Endothel. Soc., 32, 355-369.
65. Wallace, P.K., Palmer, L.D., Perry-Lalley, D., Bolton, E.S., Alexander, R.B., Horan, P.K., Yang, J.C. & Muirhead, K.A. (1993), Mechanisms of adoptive immunotherapy: improved methods for in vivo tracking of tumour-infiltrating lymphocytes and lymphokine-activated killer cells. Cancer Res., 53, 2358-2367.
66. Wang, B.S., Lumanglas, A.L. & Durr, F.E. (1986), Immunotherapy of a murine lymphoma by adoptive transfer of syngeneic macrophages activated with bisantrene. Cancer Res., 48, 503-506.
67. Yamasaki, S., Okino, T., Chakraborty, N.G., Adkisson, W.O., Sampieri, A., Padula, S.J., Mauri, F. & Mukherji, B. (1995), Presentation of synthetic peptide antigen encoded by the MAGE-1 gene by granulocyte/macrophage-colony-stimulating-factor-cultured macrophages from HLA-A1 melanoma patients. Cancer Immunol. Immunother., 40, 268-271.
68. Zitvogel, L., Mayordomo, J.I., Tjandrawan, T., DeLeo, A.B., Clarke, M.R., Lotze, M.T. & Storkus, W.J. (1996), Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J. Exp. Med., 183, 87.
69. Zou, J.P., Shimizu, J., Ikegame, K., Takiushi, H., Fujiwara, H. & Hamaoka, T. (1992), Tumor immunotherapy with the use of tumor-antigen-pulsed antigen-presenting cells. Cancer Immunol. Immunother., 35, 1.
70. Zuckerman, S.H., Ackerman, S.K. & Douglas, D. (1979), Long-term peripheral blood monocyte cultures: establishment, metabolism and morphology of primary human monocyte-macrophages cell cultures. Immunology, 38, 401-411.